Cargando…

The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis

People with Down syndrome (DS) have a neurodevelopmentally distinct brain and invariably developed amyloid neuropathology by age 50. This cross-sectional study aimed to provide a detailed account of DS brain morphology and the changes occuring with amyloid neuropathology. Forty-six adults with DS un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Annus, Tiina, Wilson, Liam R., Acosta-Cabronero, Julio, Cardenas-Blanco, Arturo, Hong, Young T., Fryer, Tim D., Coles, Jonathan P., Menon, David K., Zaman, Shahid H., Holland, Anthony J., Nestor, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391869/ https://www.ncbi.nlm.nih.gov/pubmed/28192686 http://dx.doi.org/10.1016/j.neurobiolaging.2017.01.009

Ejemplares similares

The pattern of amyloid accumulation in the brains of adults with Down syndrome
por: Annus, Tiina, et al.
Publicado: (2016)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
por: Cole, James H., et al.
Publicado: (2017)

Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivity
por: Wilson, Liam R., et al.
Publicado: (2019)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

Age-related retinal thickness in Down's syndrome: A high-risk population for dementia
por: Walpert, Madeleine J., et al.
Publicado: (2019)

Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment
por: Koike, Haruki, et al.
Publicado: (2021)

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome
por: Raha-Chowdhury, Ruma, et al.
Publicado: (2018)

In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease
por: Acosta-Cabronero, Julio, et al.
Publicado: (2013)

Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
por: Blume, Tanja, et al.
Publicado: (2022)

Measuring cerebral perfusion with [(11)C]-PiB R1 in Down syndrome: associations with amyloid burden and longitudinal cognitive decline
por: Mak, Elijah, et al.
Publicado: (2020)

The Diagnosis and Management of Autism Spectrum Disorder (ASD) in Adult Females in the Presence or Absence of an Intellectual Disability
por: Rujeedawa, Tanzil, et al.
Publicado: (2022)

Prefrontal cortical thickness in motor neuron disease
por: Machts, Judith, et al.
Publicado: (2018)

Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations
por: Acosta-Cabronero, Julio, et al.
Publicado: (2014)

Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down’s syndrome
por: Brown, Stephanie S.G., et al.
Publicado: (2022)

Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments
por: Castro, Paula, et al.
Publicado: (2016)

A Systematic Review of Unexplained Early Regression in Adolescents and Adults with Down Syndrome
por: Walpert, Madeleine, et al.
Publicado: (2021)

The Fibrillar Collagen Family
por: Exposito, Jean-Yves, et al.
Publicado: (2010)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis
por: Cardenas-Blanco, Arturo, et al.
Publicado: (2016)

FIBRILLAR DIFFERENTIATION IN MYXOMYCETE PLASMODIA
por: McManus, Sister M. A., et al.
Publicado: (1965)

Fibrillar pharmacology of functionalized nanocellulose
por: Wong, Sam, et al.
Publicado: (2021)

Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome()
por: Neale, Natalie, et al.
Publicado: (2017)

The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies
por: Lautarescu, Bianca Alexandra, et al.
Publicado: (2017)

Absence vs. presence
por: Ramkumar, Swaminathane
Publicado: (2014)

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
por: Fortea, Juan, et al.
Publicado: (2020)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

FIBRILLAR STRUCTURES IN THE CYTOPLASM OF CHAOS CHAOS
por: Nachmias, Vivianne T.
Publicado: (1964)

The fibrillar substructure of keratin filaments unraveled
Publicado: (1983)

The mechanics of fibrillar collagen extracellular matrix
por: Sun, Bo
Publicado: (2021)

Induction of retinopathy by fibrillar oxalate assemblies
por: Zaguri, Dor, et al.
Publicado: (2020)

The Presence of Consciousness in Absence Seizures
por: Bayne, Tim
Publicado: (2011)

A multi‐contrast MRI approach to thalamus segmentation
por: Corona, Veronica, et al.
Publicado: (2020)

The relationship of topographical memory performance to regional neurodegeneration in Alzheimer's disease
por: Pengas, George, et al.
Publicado: (2012)

Carbon nanotubes exhibit fibrillar pharmacology in primates
por: Alidori, Simone, et al.
Publicado: (2017)

Discovery of fibrillar adhesins across bacterial species
por: Monzon, Vivian, et al.
Publicado: (2021)

Molecular Basis of Pathogenic Variants in the Fibrillar Collagens
por: Richards, Allan J., et al.
Publicado: (2022)

Monitoring clusterin and fibrillar structures in aging and dementia
por: Trindade, Dário, et al.
Publicado: (2023)

Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease
por: Acosta-Cabronero, Julio, et al.
Publicado: (2012)

Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS)
por: Beresford-Webb, Jessica A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cidm4rldra60s808a9h5kfu49a